International Journal of Gynecological Cancer

Clinical trials in gynecological cancer
pp. 547-556(10)
Authors: TRIMBLE,; DAVIS,; DISAIA,; FUJIWARA,; GAFFNEY,; KRISTENSEN,; LEDERMANN,; PFISTERER,; QUINN,; REED,; SCHOENFELDT,; THIGPEN,

Professionals' and patients' views of routine follow-up: a questionnaire survey
pp. 557-560(4)
Authors: KEW,; GALAAL,; MANDERVILLE,; VERLEYE,

A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
pp. 561-570(10)
Authors: HESS,; BENHAM-HUTCHINS,; HERZOG,; HSU,; MALONE,; SKREPNEK,; SLACK,; ALBERTS,

Expression of the costimulatory molecule CD86, but not CD80, in keratinocytes of normal cervical epithelium and human papillomavirus-16 positive low squamous intraepithelial lesions
pp. 571-580(10)
Authors: ORTIZ-SÁNCHEZ,; CHÁVEZ-OLMOS,; PIÑA-SÁNCHEZ,; SALCEDO,; GARRIDO,

Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients
pp. 581-588(8)
Authors: SUSINI,; AMUNNI,; BUSI,; VILLANUCCI,; CARRIERO,; TADDEI,; MARCHIONNI,; SCARSELLI,

Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy
pp. 589-594(6)
Authors: SABBATINI,; MOONEY,; IASONOS,; THALER,; AGHAJANIAN,; HENSLEY,; KONNER,; SPRIGGS,; ABU-RUSTUM,; DUPONT,

Ovarian cancer incidence and survival in Korea: 1993-2002
pp. 595-600(6)
Authors: CHUNG,; HWANG,; JUNG,; WON,; SHIN,; KIM,; LEE,

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
pp. 601-606(6)
Authors: SANTILLAN,; KIM,; ZAHURAK,; GARDNER,; GIUNTOLI,; SHIH,; BRISTOW,

Cell proliferation activity unrelated to COX-2 expression in ovarian tumors
pp. 607-614(8)
Authors: YOSHIDA,; SARIAN,; ANDRADE,; PIGNATARO,; PINTO,; DERCHAIN,

Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens
pp. 615-622(8)
Authors: KHANNA,; MISHRA,; TIAN,; TAN,; ARNOLD,; LEE,; RAMACHANDRAN,; BELL,; BAQUET,; LORINCZ,

Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)
pp. 623-628(6)
Authors: LANDONI,; ZANAGNOLO,; LOVATO-DIAZ,; MANEO,; ROSSI,; GADDUCCI,; COSIO,; MAGGINO,; SARTORI,; TISI,; ZOLA,; MAROCCO,; BOTTERI,; RAVANELLI,

The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience
pp. 629-636(8)
Authors: SAHDEV,; SOHAIB,; WENADEN,; SHEPHERD,; REZNEK,

Magnetic resonance imaging appearances of recurrent cervical carcinoma
pp. 637-645(9)
Authors: BABAR,; ROCKALL,; GOODE,; SHEPHERD,; REZNEK,

Decreased prevalence of dysplasia in high-risk population immigrants in a low-risk area for cervical cancer
pp. 646-650(5)
Authors: VERMEULEN,; BOON,; GRÜNBERG,; VAN DERLINDEN-NARAIN,; VREDE,; DEKKER,; PETERS,; FLEUREN,

Human papillomavirus prevalence and predictors for cervical cancer among high-risk women from Rio de Janeiro, Brazil
pp. 651-660(10)
Authors: PEREIRA,; ROSA,; VASCONCELOS,; FARIA,; CAVALCANTI,; OLIVEIRA,

Primary treatment of Bartholin's gland carcinoma with radiation and chemoradiation: a report on ten consecutive cases
pp. 661-667(7)
Authors: LÓPEZ-VARELA,; OLIVA,; McINTYRE,; FULLER,

The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection
pp. 668-675(8)
Authors: HUANG,; YE,; CHEN,; LU,; XIE,

CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma
pp. 676-686(11)
Authors: YANG,; LEE,; WU,; CHEN,; CHANG,

Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis
pp. 687-696(10)
Authors: CHOI,; BAE,; KIM,; LEE,; PARK,; RO,; SHIN,; SEO,; AHN,

The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study
pp. 697-704(8)
Authors: ATHANASSIADOU,; ATHANASSIADES,; GRAPSA,; GONIDI,; STAMATI,; PATSOURIS,

High-grade broad ligament cancer of müllerian origin: immunohistochemical analysis of a case and review of the literature
pp. 705-709(5)
Authors: HANDA,; KATO,; KANEUCHI,; SAITOH,; YAMASHITA,

Malignant degeneration of perineal endometriosis in episiotomy scar, case report and review of the literature
pp. 709-714(6)
Authors: CHENE,; DARCHA,; DECHELOTTE,; MAGE,; CANIS,

Primary cervical choriocarcinoma: report of four cases and literature review
pp. 715-719(5)
Authors: FU,; LU,; ZHOU,; XIE,

Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature
pp. 720-723(4)
Authors: DHAR,; DAS,; BRINKMAN,; BEYNON,; WOOLAS,

Unsuspected uterine leiomyosarcoma: magnetic resonance imaging findings before and after focused ultrasound surgery
pp. 724-728(5)
Authors: FUKUNISHI,; FUNAKI,; IKUMA,; KAJI,; SUGIMURA,; KITAZAWA,

The significance of C3435T point mutation of the MDR1 gene in endometrial cancer
pp. 728-731(4)
Authors: MROZIKIEWICZ,; SEREMAK-MROZIKIEWICZ,; SEMCZUK,; LANDT,; BREBOROWICZ,; DREWS,

Occult metastatic lung carcinoma presenting as locally advanced uterine carcinosarcoma on positron emission tomography/computed tomography imaging
pp. 731-734(4)
Authors: PARINI,; MATHIS,; LEATH,

Uterine arteriovenous malformation: fertility-sparing surgery using unilateral ligation of uterine artery and ovarian ligament
pp. 735-737(3)
Authors: MILINGOS,; DOUMPLIS,; SIEUNARINE,; SAVAGE,; LAWSON,; SMITH,